Serum sickness associated with cefoxitin and pentoxifylline therapy

Area of Science:

• Immunology
• Pharmacology
• Clinical Medicine

Background:

• Human serum sickness is an immune complex-mediated syndrome with symptoms including fever, rash, and joint pain.
• Several cephalosporin antibiotics have been previously linked to serum sickness development.
• Immune complexes, formed by foreign antigens and host antibodies, are the presumed cause.

Observation:

• A patient developed serum sickness after receiving cefoxitin and pentoxifylline.
• Cefoxitin is a commonly used cephamycin antibiotic.
• Pentoxifylline is a xanthine derivative that enhances blood flow properties.

Findings:

• This case represents the first reported instance of serum sickness associated with cefoxitin use.
• This report also marks the first documented case of serum sickness linked to pentoxifylline.
• The co-administration of cefoxitin and pentoxifylline may have contributed to the adverse reaction.

Implications:

• Clinicians should be aware of the potential for cefoxitin and pentoxifylline to induce serum sickness.
• Further investigation is warranted to confirm the causal relationship between these drugs and serum sickness.
• This finding may necessitate a review of prescribing guidelines for cefoxitin and pentoxifylline in susceptible individuals.